摘要
Ozgur Ridvan LEYLEK 医师
妇科医师
Genital use of HA in women for functional and aesthetic purposes
目标: Hyaluronic Acid is a natural molecule of the human body and we can use the synthetically manufactured HA products for both volume and regeneration in many part of the body. It can also be used in female genital area for same both aims. This lecture aims to discuss the clinical use of HA in vulva and vagina.
介绍: Since the introduction of bacterial biofermentation manufacturing, hyaluronic acid (HA) has been widely and safely used in the human body for more than 30 years. In passing years, we learned many details about HA that while it can provide a volumetric effect in the injected area, but also make an acceptable regeneration as an important parameter of early wound healing procces. Since it has been used in the vagina for augmentation of anterior vaginal as called “G Shot” by Dr David Matlock, we stepped a long distance in last nearly 10 years. We will discuss vulvovaginal indications of HA.
材料 / 方法: This lecture is based on our clinical experience and previously obtained study results. We primarily address three of the most commonly used indications of hyaluronic acid (HA) in the female genital area: labia majora augmentation; intravaginal injection using the CIVIT technique for the treatment of postmenopausal genitourinary syndrome; and sexual gratification procedures, including the G-shot and I-Tongue techniques. Therefore, this section focuses on the proper indications for these three procedures.
结果: Clinical outcomes and patient satisfaction for all three procedures were strongly associated with appropriate patient selection, using of genital-proper products and correct application techniques. Despite the variability inherent in a large patient series, overall satisfactory results were achieved.
总结: Proper hyaluronic acid provides a practical and well-tolerated option for addressing selected conditions in the female genital area. However, its time-limited effectiveness and the need for further studies with long-term follow-up remain notable limitations.
披露 - Ozgur Ridvan LEYLEK
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
在REGENYAL LABORATORIES SRL提供的教育资助项下